Not Yet Recruiting
Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
NCT07583810
- Conditions
- Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Extranodal Marginal Zone Lymphoma, Gastric Mucosa-Associated Lymphoid Tissue Lymphoma, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States